Product Information
LANTHANUM CARB 1,000 MG TB CHW is a generic product labeled by Cipla USA Inc., priced at $3.1513 per EA under NDC 69097093698. Its NADAC has been published 236 times since Mar 30, 2022.
FDA first approved this application on Jan 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Cipla USA Inc.NDC
69097093698
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANTHANUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA206868FDA Approved
1/24/2022
TE Code
AB
On Market Since
1/25/2022
Pharmacological Classes
Price Statistics
The NADAC for LANTHANUM CARB 1,000 MG TB CHW has been published 236 times since Mar 30, 2022, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1513 per EA |
|---|---|
| All-time high | $7.4312 (Apr 10, 2024) |
| All-time low | $3.0689 (Aug 19, 2026) |
| 52-week high | $4.8117 |
| 52-week low | $3.0689 |
| Median price | $4.7605 |
| Average price | $5.0810 |
| Largest weekly change | +41.1% (Jan 17, 2024) |
| Weeks tracked | 236 |
| Tracking since | Mar 30, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LANTHANUM CARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANTHANUM CARB 1,000 MG TB CHW?
The current National Average Drug Acquisition Cost (NADAC) for LANTHANUM CARB 1,000 MG TB CHW, manufactured by Cipla USA Inc., is $3.1513 per EA (NDC 69097093698), effective Sep 30, 2026.
How has the price of LANTHANUM CARB 1,000 MG TB CHW changed over time?
Over the history we have for it, the NADAC for LANTHANUM CARB 1,000 MG TB CHW has declined 56.6%. It has been tracked across 236 weekly CMS publications since Mar 30, 2022.
What are the highest and lowest recorded NADAC prices for LANTHANUM CARB 1,000 MG TB CHW?
Since Mar 30, 2022, the NADAC for LANTHANUM CARB 1,000 MG TB CHW has ranged from a low of $3.0689 (Aug 19, 2026) to a high of $7.4312 (Apr 10, 2024), with a median of $4.7605 per EA.
Are there cheaper alternatives to LANTHANUM CARB 1,000 MG TB CHW?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANTHANUM CARB 1,000 MG TB CHW in a comparable dosage form, but none are currently priced below it.
Who manufactures LANTHANUM CARB 1,000 MG TB CHW?
LANTHANUM CARB 1,000 MG TB CHW (NDC 69097093698) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.